Efficacy and Safety of CAR-Modified T Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Prospective Clinical Trials

Efficacy and Safety of CAR-Modified T Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Prospective Clinical Trials

Background: In recent years, chimeric antigen receptor-modified T (CAR-T) cell therapy for B-cell leukemia and lymphoma has shown high clinical efficacy. Similar CAR-T clinical trials have also been carried out in patients with refractory/relapsed multiple myeloma (RRMM). However, no systematic revi...

Full description

Bibliographic Details
Main Authors: Xinrong Xiang, Qiao He, Yang Ou, Wen Wang, Yu Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Pharmacology
Subjects:
chimeric antigen receptor
cancer immunotherapy
multiple myeloma
efficacy
safety
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2020.544754/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2020.544754/full

Similar Items